Lyra Therapeutics Files 2024 10-K

Ticker: LYRA · Form: 10-K · Filed: Mar 13, 2025 · CIK: 1327273

Lyra Therapeutics, INC. 10-K Filing Summary
FieldDetail
CompanyLyra Therapeutics, INC. (LYRA)
Form Type10-K
Filed DateMar 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, medical-devices

TL;DR

Lyra Therapeutics filed its 2024 10-K. All systems go.

AI Summary

Lyra Therapeutics, Inc. filed its 2024 10-K on March 13, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Arsenal Medical, Inc., is focused on surgical and medical instruments. The filing details its business address in Watertown, MA, and includes information on its fiscal year end and SEC filing details.

Why It Matters

This filing provides a comprehensive overview of Lyra Therapeutics' financial performance and business operations for the fiscal year 2024, crucial for investors and stakeholders to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This is a standard annual report filing with no immediate red flags or significant new disclosures that would indicate elevated risk.

Key Numbers

Key Players & Entities

FAQ

What is Lyra Therapeutics, Inc.'s primary business classification?

Lyra Therapeutics, Inc. is classified under SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841].

When was Lyra Therapeutics, Inc. formerly known as Arsenal Medical, Inc.?

The company changed its name from Arsenal Medical, Inc. on April 14, 2009.

What is the physical address of Lyra Therapeutics, Inc.?

The business and mailing address for Lyra Therapeutics, Inc. is 480 Arsenal Way, Watertown, MA 02472.

What is the filing date of this 10-K report?

This 10-K report was filed on March 13, 2025.

What fiscal period does this 10-K report cover?

This 10-K report covers the fiscal year ending December 31, 2024.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 13, 2025 regarding Lyra Therapeutics, Inc. (LYRA).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing